Welcome to our dedicated page for Stride SEC filings (Ticker: LRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stride, Inc. filings document the public-company disclosures of an online education provider, including quarterly operating results furnished on Form 8-K and proxy materials for annual stockholder matters. The filings cover revenue and earnings releases, adjusted financial measures, enrollment-related reporting, and management commentary on fiscal-year expectations.
Stride’s regulatory documents also address governance and capital structure topics, including stock repurchase disclosures, board composition and committee assignments, equity incentive plan amendments, employee stock purchase plan approval, executive compensation matters, and stockholder voting results. These filings provide the formal record for the company’s education operations, governance framework, and shareholder-approved compensation plans.
Stride, Inc. reported an equity award to one of its non-employee directors in the form of deferred stock units. On 12/04/2025, the director acquired 4,097 deferred stock units under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors at a price of $0 per unit. Each deferred stock unit is economically equivalent to one share of Stride common stock and becomes payable when the director’s board service ends. These new units will vest on the earlier of December 4, 2026, or the next annual meeting of Stride stockholders. Following this grant, the director beneficially owns 16,955 derivative securities in the form of deferred stock units, held directly.
Stride, Inc.December 4, 2025, the non-employee director received 4,097 Deferred Stock Units (DSUs) under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors. Each DSU is the economic equivalent of one share of Stride common stock, and any fractional shares will be settled in cash.
The DSUs will vest on the earlier of December 4, 2026 or the next annual meeting of Stride stockholders. After this award, the director beneficially owns 12,333 derivative securities, reported as held directly. The DSUs are payable when the director’s board service ends, so this grant defers compensation into equity aligned with the company’s share performance.
Stride, Inc. reported a routine insider transaction involving one of its directors. On December 4, 2025, the director acquired 4,097 shares of Stride common stock as a restricted stock award at a stated price of $0, reflecting an equity-based compensation grant rather than an open-market purchase.
After this grant, the director beneficially owns 6,359 shares of Stride common stock in direct ownership form. The filing notes that these restricted shares will vest on the earlier of December 4, 2026, or the next annual meeting of Stride’s stockholders, tying the award to continued board service and the company’s regular governance calendar.
Stride, Inc. reported that one of its directors received an award of 4,097 Deferred Stock Units (DSUs) on December 4, 2025 under the Stride, Inc. Deferred Compensation Plan for Non-Employee Directors. Each DSU is the economic equivalent of one share of Stride common stock and is payable after the director’s service ends, with any fractional share settled in cash.
The DSUs will vest on the earlier of December 4, 2026 or the next annual meeting of Stride’s stockholders. Following this grant, the director beneficially owns 13,218 derivative securities related to Stride common stock, held directly.
Stride, Inc. reported that a director received a grant of 4,097 shares of restricted common stock on December 4, 2025 at a price of $0 per share. Following this grant, the director beneficially owns 6,551 shares of Stride common stock in total, held directly. These restricted shares will vest on the earlier of December 4, 2026 or the next annual meeting of Stride’s stockholders, aligning the director’s compensation with the company’s future performance.
Stride, Inc. director reported receiving a grant of restricted common stock. On 12/04/2025, an indirect account, the S&C Fink Living Trust, acquired 4,097 shares of Stride common stock at a stated price of $0, reflecting an equity award rather than an open‑market purchase. After this grant, the trust holds 175,607 shares of Stride common stock indirectly. These restricted shares will vest on the earlier of December 4, 2026, or the next annual meeting of Stride stockholders.
Stride, Inc. reported an equity grant to one of its directors. On December 4, 2025, the director acquired 4,097 shares of Stride common stock at a price of $0, reflecting a restricted stock award rather than an open-market purchase. Following this transaction, the director beneficially owns 42,201 shares, held directly.
The new shares are restricted and will vest on the earlier of December 4, 2026 or the date of the next annual meeting of Stride, Inc. stockholders. This filing is a routine Form 4 disclosure of director equity compensation and does not describe any broader corporate events or financial results.
Stride, Inc. (LRN) insider Form 4 filing reports a stock gift. The company’s Chief Executive Officer and director reported a bona fide gift of 25,177 shares of Stride common stock on 11/19/2025, recorded with transaction code "G" at a reported price of $0 per share. After this gift, the reporting person beneficially owns 752,009 shares of Stride common stock in direct ownership form. This filing reflects a change in the executive’s personal holdings and does not describe any company-level financing or business transaction.
Stride, Inc. announced a stock repurchase program authorizing the buyback of up to $500 million of its common stock, effective November 3, 2025 and running until October 31, 2026.
Repurchases may occur from time to time via open market purchases, privately negotiated transactions, or otherwise, in accordance with SEC rules and other legal requirements. The timing, price, and size of any purchases will depend on prevailing stock prices, general economic and market conditions, and other considerations.
The program does not obligate Stride to repurchase any particular amount of shares and may be suspended or discontinued at any time at the Company’s discretion.
The Vanguard Group filed an amended Schedule 13G disclosing beneficial ownership of 4,542,733 shares of Stride Inc (LRN) common stock, representing 10.41% of the class as of 09/30/2025.
The filing reports 0 shares with sole voting power and 294,332 with shared voting power. Vanguard has 4,192,875 shares with sole dispositive power and 349,858 with shared dispositive power. Vanguard states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.